BioCryst Pharmaceuticals (BCRX) Earnings Date, Estimates & Call Transcripts $9.98 +0.06 (+0.60%) As of 05/9/2025 03:58 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BioCryst Pharmaceuticals Earnings Summary BioCryst Pharmaceuticals posted Q4 2024 earnings on February 24, 2025, reporting an EPS of -$0.13, which missed the consensus estimate of -$0.07 by $0.06. Quarterly revenue rose 40.8% year-over-year to $131.50 million, above analyst estimates of $126.64 million. With a trailing EPS of -$0.26, BioCryst Pharmaceuticals' earnings are expected to grow next year, from ($0.36) to ($0.07) per share. Latest Q4 Earnings DateFeb. 24EstimatedConsensus EPS (Feb. 24) -$0.07 Actual EPS (Feb. 24) -$0.13 Missed By -$0.06 Actual Revenue (Feb. 24) $131.50MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get BioCryst Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioCryst Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBCRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BCRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BioCryst Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.06-$0.06-$0.06Q2 20252$0.00$0.10$0.05Q3 20252$0.04$0.13$0.09Q4 20252$0.07$0.13$0.10 FY 2025 7 $0.05 $0.30 $0.18 Q1 20261$0.11$0.11$0.11Q2 20261$0.14$0.14$0.14Q3 20261$0.09$0.09$0.09Q4 20261$0.17$0.17$0.17 BioCryst Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails2/24/2025Q4 2024-$0.07-$0.13 -$0.06-$0.13$126.64M$131.50M11/4/2024Q3 2024-$0.07-$0.07--$0.07$113.99M$117.10M8/5/2024Q2 2024-$0.17-$0.06+$0.11-$0.06$98.30M$109.30M5/6/2024Q1 2024-$0.23-$0.17+$0.06-$0.17$85.62M$92.80M2/26/2024Q4 2023-$0.24-$0.28 -$0.04-$0.25$89.19M$93.40M11/2/2023Q3 2023-$0.25-$0.19+$0.06-$0.19$86.54M$86.74M8/3/2023Q2 2023-$0.25-$0.24+$0.01-$0.08$81.42M$81.01M BioCryst Pharmaceuticals Earnings - Frequently Asked Questions When did BioCryst Pharmaceuticals announce their last quarterly earnings? BioCryst Pharmaceuticals (NASDAQ:BCRX) last announced its quarterly earning data on Monday, February 24, 2025. Learn more on BCRX's earnings history. What guidance has BioCryst Pharmaceuticals issued on next quarter's earnings? BioCryst Pharmaceuticals issued an update on its FY 2025 earnings guidance on Saturday, March, 1st. The company issued revenue guidance of $560.0 million-$575.0 million, compared to the consensus revenue estimate of $628.8 million. Did BioCryst Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, BioCryst Pharmaceuticals (NASDAQ:BCRX) missed the analysts' consensus estimate of ($0.07) by $0.06 with a reported earnings per share (EPS) of ($0.13). Learn more on analysts' earnings estimate vs. BCRX's actual earnings. How can I listen to BioCryst Pharmaceuticals's earnings conference call? The conference call for BioCryst Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read BioCryst Pharmaceuticals's conference call transcript? The conference call transcript for BioCryst Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does BioCryst Pharmaceuticals generate each year? BioCryst Pharmaceuticals (NASDAQ:BCRX) has a recorded annual revenue of $503.49 million. How much profit does BioCryst Pharmaceuticals generate each year? BioCryst Pharmaceuticals (NASDAQ:BCRX) has a recorded net income of -$226.54 million. BCRX has generated -$0.26 earnings per share over the last four quarters. What is BioCryst Pharmaceuticals's EPS forecast for next year? BioCryst Pharmaceuticals's earnings are expected to grow from ($0.36) per share to ($0.07) per share in the next year. More Earnings Resources from MarketBeat Related Companies RGEN Earnings Date HALO Earnings Date MDGL Earnings Date IONS Earnings Date ALKS Earnings Date LGND Earnings Date FOLD Earnings Date MNKD Earnings Date DVAX Earnings Date CLDX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming?DexCom Stock: Earnings Beat and New Market Access Drive Bull CaseDisney Stock Jumps on Earnings—Is the Magic Sustainable? This page (NASDAQ:BCRX) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThis next market event could mean total financial ruin for someYou think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCryst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCryst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCRX Stock Free BCRX Stock Alerts